
快訊
Pfizer accuses Novo Nordisk of conspiring to evade antitrust scrutiny and "stifling an emerging competitor" by sabotaging Pfizer's deal with Metsera

Pfizer accuses Novo Nordisk of conspiring to evade antitrust scrutiny and "stifling an emerging competitor" by sabotaging Pfizer's deal with Metsera